FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Johnson Bankole A.
2. Date of Event Requiring Statement (Month/Day/Year)
07/26/2018
3. Issuer Name and Ticker or Trading Symbol
ADIAL PHARMACEUTICALS, INC. [ADIL]
(Last)
(First)
(Middle)
1180 SEMINOLE TRAIL, SUITE 495
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

CHARLOTTESVILLE, VA 22901
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 102,654
D
 
Common Stock 850,896
I
En Fideicomiso De Mi Vida 11/23/2010 (Trust) (1)
Common Stock 93,000
I
En Fidecomiso de Todos Mis Suenos Grantor Retained Annuity Trust dated June 27, 2017 (1)
Common Stock 22,320
I
En Fideicomiso De Mis Suenos 11/23/2010 (Trust) (1)
Common Stock 7,440
I
De Mi Amor 11/23/2010 (Trust) (1)
Common Stock 4,650
I
Efunbowale Johnson (2)
Common Stock 1,395
I
Ade Johnson (2)
Common Stock 1,395
I
Lola Johnson (2)
Common Stock 930
I
Lina Tiouririne (2)
Common Stock 930
I
Aida Tiouririne (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant 10/10/2017 12/31/2031 Common Stock 3,275 $ 7.63 D  
Stock Option 01/01/2018 06/30/2027 Common Stock 5,580 (3) $ 5.7 D  
Convertible Note   (4)   (4) Common Stock 153,114 (4) $ 0.44 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Johnson Bankole A.
1180 SEMINOLE TRAIL, SUITE 495
CHARLOTTESVILLE, VA 22901
  X   X    
En Fidecomiso de Mi Vida 11/23/2010 Trust
11024 GAITHER FARM ROAD
ELLICOTT CITY, MD 21042
    X    

Signatures

/s/ Bankole A. Johnson 07/26/2018
**Signature of Reporting Person Date

En Fideicomiso De Mi Vida 11/23/2010 (Trust) By: /s/ Bankole A. Johnson 07/26/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Dr. Johnson is the trustee of each of these trusts.
(2) Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.
(3) The option has an exercise price of $5.70 per share and vests as to 1/6th of the grant on January 1, 2018 with the remaining shares vesting 1/36th on the first day of each month over the remaining 30 months.
(4) 153,114 shares issued upon consummation of this offering upon automatic conversion of a convertible note in the principal amount of $52,000 at a conversion price of $0.44 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.